Scientific and research excellence by clinical chemistry students and trainees is recognized through the Grannis award. The late George Grannis was the second President of the Academy. A man of great curiosity, profound thinking, and creativity, Dr. Grannis’ interests and published research included findings in the areas of protein biochemistry in health and disease, normal and abnormal blood coagulation, proficiency evaluation of clinical laboratories, biochemistry of aging, and quality control of enzyme analyses.
This award includes a guest lectureship at an Ohio Valley Local Section meeting during the year of the award. All current and past students in undergraduate, graduate, or postdoctoral clinical chemistry training programs who were enrolled sometime during the three-year period prior to the year of the award will be considered candidates for this award. The student must have published a paper indexed in Index Medicus during this same time period. Names of students from ComACC-accredited programs may be submitted by the program director. Names of students from non-ComACC-accredited programs may be submitted by their mentors. The nomination should include a letter of nomination, a list of papers authored by the student, and a copy of the trainee's curriculum vitae. Literature references should include sufficient information to locate the papers; links to PubMed abstracts are suitable.
Sponsored by AACC Academy and the Ohio Valley Local Section.
Congratulations to This Year's Winner!
Xander van Wijk, PhD, DABCC
Xander van Wijk, PhD, DABCC is an Assistant Professor of Pathology at the University of Chicago, the Assistant Director of Clinical Chemistry and Pharmacogenomics Laboratories and the Director of the Rapid Response Laboratory at UChicago Medicine. He obtained his PhD in Medical Sciences in the Department of Biochemistry at the Radboud University Nijmegen, the Netherlands and did postdoctoral research at the University of California San Diego. He completed his fellowship in Clinical Chemistry in the ComACC accredited postdoctoral training program at the University of California San Francisco. His primary research areas are Clinical Pharmacogenomics, Toxicology, and Cardiac Biomarkers and he has (co-) authored more than 30 peer-reviewed articles and book chapters. He received a postdoctoral fellowship award from the American Heart Association and a general research grant from the AACC for his work on cardiac troponin. He is interested in identifying specific forms of troponin that correlate with disease status.